BOSTON, Dec. 11, 2017 /PRNewswire/ -- MedyMatch Technology today announced that it has been named by FierceMedTech as one of 2017's Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.
MedyMatch has developed a broad machine vision and artificial intelligence platform to support the assessment of multiple clinical indications. MedyMatch's team of A.I., deep learning and machine vision experts with world-class clinical partners are combining clinical expertise with machine vision/learning to yield unprecedented insight into unstructured medical data. The first of these applications to be available, begins with the detection of intracranial hemorrhage, used as part of clinical decision support for stroke assessment and head trauma. Working with our distribution partners, MedyMatch is on a mission to make all caregivers confident, life-saving experts every time and in all locations through A.I.-enabled clinical decision support at the point of care.
"It is an honor to be highlighted as one of 2017s Fierce 15 from the publishers of FierceMedTech," said Gene Saragnese, Chairman & CEO of MedyMatch. "Our broad access to global markets through our distribution partners such as GE Healthcare, IBM Watson Health and Samsung is fulfilling our mission of making A.I. accessible and positively impacting patient outcomes."
The Fierce 15 celebrates the spirit of being "fierce" – championing innovation and creativity, even in the face of intense competition. Read more at https://www.fiercebiotech.com/special-report/medymatch
An internationally recognized daily report reaching a network of over 90,000 med tech industry professionals, FierceMedTech provides subscribers with an authoritative analysis of the day's top stories. Every year FierceMedTech evaluates hundreds of private companies from around the world for its annual Fierce 15 list, which is based on a variety of factors such as the strength of its technology, partnerships, venture backers and a competitive market position.
Based in Tel Aviv, Israel, MedyMatch is a leading medical A.I. company delivering real-time clinical decision support platform to improve patient outcomes in acute medical scenarios. The platform can be natively integrated into PACS systems, medical imaging hardware or healthcare clouds. To learn more, please visit https://www.medymatch.com. Join the conversation at #medymatch and follow us on twitter at @medymatch.
SOURCE MedyMatch Technology